🇺🇸 FDA
Patent

US 8017578

Orally active peptides that prevent cell damage and death

granted A61KA61K38/04A61K38/185

Quick answer

US patent 8017578 (Orally active peptides that prevent cell damage and death) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/04, A61K38/185